PARK7 and glioblastoma: Interestingly, we found that high expression of PARK7 in GBM significantly correlated with poorer patient survival and an increased 1.82‐fold risk of death compared with low PARK7 expression (cutoff: median FPKM; p < .0001) (Figure S1F–H).